Clinical use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council Countries

Trial Identifier:	D8851R00001
Sponsor:	AstraZeneca
NCTID::	NCT05315323
Start Date:	June 2022
Primary Completion Date:	June 2024
Study Completion Date:	June 2024
Condition:	COVID-19 Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Arab Emirates	Abu Dhabi, United Arab Emirates

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.